To understand, predict and diagnose
hepatobiliary tumors in places where the need strikes the most
THE ESCALON PROJECT
The overall aim of the project is to develop cost-effective tools for the early diagnosis of hepatobiliary cancers in Latin America and to identify factors that allow for risk stratification and primary prevention for these tumors.
Read more
WP 1 hepatocellular carcinoma
Hepatocellular carcinoma, affecting hepatocytes, is the most common type of hepatobiliary cancer. In ESCALON we will address serum markers for prediction of hepatocellular carcinoma and identification of risk factors associated with early development of this cancer in Latin America.
WP 2 cholangiocarcinoma
Cholangiocarcinoma develops from the bile ducts and is a rare type of cancer. In ESCALON, we will assess diagnostic biomarkers and evaluate genetic and infectious determinants of cholangiocarcinoma in Latin America.
WP 3 gallbladder carcinoma
Gallbladder carcinoma is quite rare in Europe, but very common in parts of Latin-America. In ESCALON, we will evaluate biomarkers for early diagnosis of gallbladder cancer and characterize immune-related variables to define ancestry-dependent risk.
WP 1 hepatocellular carcinoma
Hepatocellular carcinoma, affecting hepatocytes, is the most common type of hepatobiliary cancer. In ESCALON we will address serum markers for prediction of hepatocellular carcinoma and identification of risk factors associated with early development of this cancer in Latin America.
